Newsletters
oncology
- 2024-07-26 - 🧬 [nGram] Today’s Oncology Scoop: FDA Grants Orphan Drug Status to Cellectis’ UCART22, Summit & MD Anderson Collaboration, Presage Biosciences Doses First Patient
- 2024-07-25 - 🧬 [nGram] Today’s Oncology Scoop: Inimmune Doses First Patient, Novartis Collaboration, Notable Labs FDA Clearance
- 2024-07-24 - 🧬 [nGram] Today’s Oncology Scoop: AffyImmune RMAT, BioAtla Fast Track, Anixa IND
- 2024-07-23 - 🧬 [nGram] Today’s Oncology Scoop: Immutep's FDA Success, BeiGene's New Facility, and More
- 2024-07-22 - 🧬 [nGram] Today’s Oncology Scoop: Nuvalent Doses First Patient, Zymeworks FDA Clearance, TME Pharma Strategy
- 2024-07-19 - 🧬 [nGram] Today’s Oncology Scoop: Bristol Myers Squibb's Opdivo, AVEO's Phase 3 Results, Deciphera's EMA Application
- 2024-07-18 - 🧬 [nGram] Today’s Oncology Scoop: Junshi's New Drug Application & Biotheryx's Phase 1 Trial
- 2024-07-17 - 🧬 [nGram] Today’s Oncology Scoop: Bayer's NUBEQA® Phase III Success, FDA Orphan Drug Designations
- 2024-07-16 - 🧬 [nGram] Today’s Oncology Scoop: Biosyngen's BRG01 Phase II, Mabwell's NMPA Approval, GRAIL's Galleri® Trial
- 2024-07-12 - 🧬 [nGram] Today’s Oncology Scoop: Senhwa IND, Revolution Medicines, KOLON Phase III
- 2024-07-11 - 🧬 [nGram] Today’s Oncology Scoop: Rgenta's IND Clearance, Kazia's Phase II/III Results, Can-Fite's Orphan Drug Application
- 2024-07-10 - 🧬 [nGram] Today’s Oncology Scoop: Obsidian's FDA Fast Track, Curium's NDA, Prelude & Merck Collaboration
- 2024-07-09 - 🧬 [nGram] Today’s Oncology Scoop: SELLAS Orphan Drug, iOnctura NSCLC Trial, Radionetics-Lilly Deal
- 2024-07-08 - 🧬 [nGram] Today’s Oncology Scoop: Immorna, IDEAYA, Hinova, Biostar, iTeos, Myricx, XPOVIO, Olverembatinib, IASO
- 2024-07-05 - 🧬 [nGram] Today’s Oncology Scoop: Breakthrough in Breast Cancer Treatment, New Drug Approval, and More
- 2024-07-04 - 🧬 [nGram] Today’s Oncology Scoop: Roche's SKYSCRAPER-06 Update, Boehringer's SIRP Treatment, HUTCHMED's NDA
- 2024-07-03 - 🧬 [nGram] Today’s Oncology Scoop: Legend Biotech's CARTITUDE-4, Biogen's Acquisition, Full-Life's FDA Fast Track
- 2024-07-02 - 🧬 [nGram] Today’s Oncology Scoop: Allogene's Phase 2 Trial, Ipsen's Cabometyx Expansion, Orion & MSD's Opevesostat Deal
- 2024-07-01 - 🧬 [nGram] Today’s Oncology Scoop: BALVERSA® & RYBREVANT® Get EU Nod, SCG Cell Therapy FDA IND Clearance
- 2024-06-28 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approvals, New Data, and Clinical Trial Updates
- 2024-06-27 - 🧬 [nGram] Today’s Oncology Scoop: EPKINLY® FDA Approval, GenVivo Trial, Cancer Drug Shortage
- 2024-06-26 - 🧬 [nGram] Today’s Oncology Scoop: Lyell's CAR-T, Simcere's Cetuximab, Junshi's Toripalimab
- 2024-06-25 - 🧬 [nGram] Today’s Oncology Scoop: IMFINZI® Success, Oncoinvent Fast Track, Merck KGaA Update
- 2024-06-24 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approvals, Clinical Updates & More
- 2024-06-21 - 🧬 [nGram] Today’s Oncology Scoop: Allogene's Phase 2 Trial, Oncolytics' New Study, Tempest's Survival Data
- 2024-06-20 - 🧬 [nGram] Today’s Oncology Scoop: Basilea Partners with Glioblastoma Foundation, iOnctura Secures EUR80M
- 2024-06-19 - 🧬 [nGram] Today’s Oncology Scoop: GenFleet's IND Approval, Golidocitinib's New Approval, Medivir's Phase 2b Study, Aethlon's Ethics Approval
- 2024-06-18 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Merck’s KEYTRUDA, Junshi's sNDA for Toripalimab, Evaxion's 67% Response Rate
- 2024-06-17 - 🧬 [nGram] Today’s Oncology Scoop: IMFINZI® Approval, Roche’s Columvi Success, BLINCYTO® FDA Nod
- 2024-06-14 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Augtyro™, ASCO 2024 Highlights, and More
- 2024-06-13 - 🧬 [nGram] Today’s Oncology Scoop: MSK's Pancreatic Cancer Breakthrough, Innovent's FDA Fast Track, Immorta Bio's Lung Cancer Success
- 2024-06-12 - 🧬 [nGram] Today’s Oncology Scoop: City of Hope CAR T Cell Therapy, Junshi Biosciences Phase 3 Success, OBI Pharma's New Study
- 2024-06-11 - 🧬 [nGram] Today’s Oncology Scoop: FDA Clears Lomonitinib, SL-172154 Orphan Drug, Ultimovacs Phase I Update
- 2024-06-10 - 🧬 [nGram] Today’s Oncology Scoop: Roche’s Alecensa Approved, TAGRISSO® Priority Review, Zymeworks in China
- 2024-06-07 - 🧬 [nGram] Today’s Oncology Scoop: FDA Approves Geron's RYTELO™, AbbVie's Positive Phase 2 Results, and More
- 2024-06-06 - 🧬 [nGram] Today’s Oncology Scoop: BridgeBio Doses First Patient, AbbVie Starts Ph. 3 Trial, Replimune Positive Data
- 2024-06-05 - 🧬 [nGram] Today’s Oncology Scoop: Bristol Myers Squibb's Opdivo/Yervoy Success, Pierre Fabre's IND Filing, MAIA's THIO Efficacy
Charts
